GLICLADA®

Prolonged-release tablet, 60mg
RxActive license

Active substance (INN)

gliclazide

Pharmaceutical form

Pharmaceutical formProlonged-release tablet
Strength60mg
PackagingUkupno 30 tableta sa produženim oslobađanjem u blisteru (2x15) u kartonskoj kutiji
ManufacturerKrka d.d., Slovenia
Therapeutic groupAlimentary tract and metabolism (A10BB09)
Marketing authorization holderDIO STRANOG DRUŠTVA "KRKA D.D. NOVO MESTO" SLOVENIJA - PREDSTAVNIŠTVO PODGORICA
Authorization dateOctober 19, 2022

Analogs in Montenegro

3

Other medicines with the same active substance

DIAPREL MRRx
Modified-release tablet, 60mgLes Laboratoires Servier Industrie
DIAPREL MRRx
Modified-release tablet, 60mgLes Laboratoires Servier Industrie
GLIORALRx
Tablet, 80mgGalenika a.d. Beograd
Source: CInMED register